Literature DB >> 12588013

The molecular epidemiology of tuberculosis in western Canada.

J M FitzGerald1, A Fanning, V Hoepnner, E Hershfield, D Kunimoto.   

Abstract

OBJECTIVE: To define the molecular epidemiology of TB in western Canada, and in particular the risk factors for clustering. MEASUREMENTS: We prospectively identified all positive cultures from newly diagnosed cases of TB diagnosed between February 1995 and January 1997 and carried out restriction fragment length polymorphism (RFLP) testing on all isolates.
RESULTS: Of 956 cases identified, 944 fulfilled the entry criteria. The mean age was 49.65 years (+/- 22.33), and 508 (53.6%) were males. Three hundred and three (32.1%) subjects were clustered; this varied from 20.2% of the foreign born, 48.4% of Canadian non-Aboriginal and 61.1% of all Aboriginal persons. Younger persons (P = 0.0001), males (P = 0.015), those with pulmonary disease (P < 0.001), living in a shelter in the past year (P < 0.001), drug-susceptible disease (P < 0.036), predisposing factors (P < 0.001), prior contact (P < 0.001), and prior skin test (P < 0.002) were more likely to cluster. Among specific risk factors, HIV infection, injection drug use, alcohol excess, and weight loss were all significant.
CONCLUSIONS: In this description of the molecular epidemiology of TB in Western Canada, previous results have been confirmed and extended. These results highlight the importance of identifying specific high risk groups, especially in the context of renewed efforts to target persons for treatment of latent TB infection.

Entities:  

Mesh:

Year:  2003        PMID: 12588013

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Sustained intra- and inter-jurisdictional transmission of tuberculosis within a mobile, multi-ethnic social network: lessons for tuberculosis elimination.

Authors:  Anne Aspler; Huey Chong; Dennis Kunimoto; Linda Chui; Evelina Der; Jody Boffa; Richard Long
Journal:  Can J Public Health       Date:  2010 May-Jun

Review 2.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

3.  Predicting tuberculosis risk in the foreign-born population of British Columbia, Canada: study protocol for a retrospective population-based cohort study.

Authors:  Lisa A Ronald; Jonathon R Campbell; Robert F Balshaw; David Z Roth; Kamila Romanowski; Fawziah Marra; Victoria J Cook; James C Johnston
Journal:  BMJ Open       Date:  2016-11-25       Impact factor: 2.692

4.  Universal genotyping reveals province-level differences in the molecular epidemiology of tuberculosis.

Authors:  Jennifer L Guthrie; Alex Marchand-Austin; Kirby Cronin; Karen Lam; Daria Pyskir; Clare Kong; Danielle Jorgensen; Mabel Rodrigues; David Roth; Patrick Tang; Victoria J Cook; James Johnston; Frances B Jamieson; Jennifer L Gardy
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

5.  Examining DNA fingerprinting as an epidemiology tool in the tuberculosis program in the Northwest Territories, Canada.

Authors:  Cheryl Case; Kami Kandola; Linda Chui; Vincent Li; Nancy Nix; Rhonda Johnson
Journal:  Int J Circumpolar Health       Date:  2013-05-08       Impact factor: 1.228

6.  Influence of Hospitalization upon Diagnosis on the Risk of Tuberculosis Clustering.

Authors:  Giuseppe Lapadula; Fabio Zanini; Luigi Codecasa; Fabio Franzetti; Maurizio Ferrarese; Manuela Carugati; Ester Mazzola; Consuelo Schiroli; Davide Motta; Diego Iemmi; Andrea Gori
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-20       Impact factor: 2.576

7.  Molecular Epidemiology of Tuberculosis in British Columbia, Canada: A 10-Year Retrospective Study.

Authors:  Jennifer L Guthrie; Clare Kong; David Roth; Danielle Jorgensen; Mabel Rodrigues; Linda Hoang; Patrick Tang; Victoria Cook; James Johnston; Jennifer L Gardy
Journal:  Clin Infect Dis       Date:  2018-03-05       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.